Skip to main content
Sartorius AG logo

Sartorius AG — Investor Relations & Filings

Ticker · SRT3 ISIN · DE0007165607 LEI · 529900EQV2DY4FOAMU38 F Manufacturing
Filings indexed 392 across all filing types
Latest filing 2023-04-04 Annual Report
Country DE Germany
Listing F SRT3

About Sartorius AG

https://www.sartorius.com/en

Sartorius is a leading international partner for the biopharmaceutical industry and life science research. The company provides a comprehensive portfolio of products and services that support the entire drug development and manufacturing process, from initial discovery to production. Key offerings include advanced solutions for filtration, fermentation, fluid management, cell analysis, and process analytics. The laboratory products division supplies essential equipment such as balances, pipettes, and water purification systems. Sartorius focuses on simplifying complex scientific processes to help customers translate discoveries into effective medicines more quickly and efficiently.

Recent filings

Filing Released Lang Actions
Konzernabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
Annual Report Classification · 95% confidence The document is a detailed corporate report describing the company's organizational structure, business segments, strategic focus, acquisitions, financial management, and medium-term goals. It includes extensive narrative on the company's strategy, portfolio, and financial indicators, typical of a comprehensive annual report. There is no indication that this is a short announcement or a certification letter. The length (15,000 characters) and content depth confirm it is a full report rather than a brief announcement or presentation. The document does not focus on quarterly or interim results, nor is it a transcript, proxy, or legal update. The detailed discussion of business segments, strategy, and financial steering aligns with the characteristics of an Annual Report (10-K equivalent). FY 2022
2023-04-04 German
SARTORIUS AG: Sartorius to acquire Polyplus
M&A Activity Classification · 99% confidence The document is a press release announcing that Sartorius AG has signed an agreement to acquire Polyplus for approximately 2.4 billion euros. The key phrase indicating the nature of the filing is 'EQS-News: SARTORIUS AG / Key word(s): Mergers & Acquisitions'. This clearly identifies the content as an announcement related to a merger or takeover bid. Therefore, the appropriate classification is M&A Activity (TAR). The document is a full announcement, not just a notice that a report is attached, so RPA is not the primary choice.
2023-03-31 English
SARTORIUS AG: Alexandra Gatzemeyer joins Executive Board of Sartorius to lead the Lab Products & Services division
Board/Management Information Classification · 100% confidence The document is a press release announcing a change in senior management: Alexandra Gatzemeyer joining the Executive Board and succeeding Gerry Mackay. This directly corresponds to the definition of Board/Management Information. The keywords 'Executive Board', 'Supervisory Board', 'appointed', and the announcement of personnel changes confirm this classification. The document is not a full financial report (10-K, IR) or a general regulatory filing (RNS), but a specific personnel announcement.
2023-03-29 English
SARTORIUS AG: Resolutions of the Annual General Meeting of Sartorius AG
AGM Information Classification · 99% confidence The document explicitly states in the title and body: "Resolutions of the Annual General Meeting of Sartorius AG". It details the outcomes of the meeting, including dividend approvals. This directly corresponds to the definition of AGM Information (AGM-R). Although it mentions dividend distribution (which could relate to DIV), the primary context is the summary of all resolutions passed at the Annual General Meeting.
2023-03-29 English
Jahresabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
Annual Report Classification · 95% confidence The document is a detailed narrative about the company's organizational structure, business model, strategy, financial control metrics, and portfolio changes. It includes extensive discussion of the company's operations, strategic focus, and financial indicators for the fiscal year ending December 31, 2022. The text is consistent with a comprehensive annual report or management discussion section of such a report. There is no indication that this is a short announcement or a certification letter. The length (15,000 characters) and depth of content suggest it is part of a full Annual Report (10-K equivalent). The document does not fit other categories such as earnings release, call transcript, or regulatory filing. Therefore, the best classification is Annual Report (10-K). FY 2022
2023-03-21 German
Sartorius Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 29.03.2023 in Gottingen mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 99% confidence The document is explicitly titled 'Bekanntmachung der Einberufung zur Hauptversammlung' (Announcement of the Convocation to the General Meeting) and details the agenda for the 'Ordentliche Hauptversammlung 2023' (Ordinary General Meeting 2023) scheduled for March 29, 2023. It discusses items typically voted upon at an AGM, such as dividend proposals, discharge of management/supervisory boards, auditor election, and approval of remuneration systems. This content directly relates to the preparation and announcement of the Annual General Meeting. Therefore, the appropriate classification is AGM-R (AGM Information).
2023-02-17 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.